ATE364690T1 - Posh nukleinsäure, polypeptide und darauf bezogene verfahren - Google Patents

Posh nukleinsäure, polypeptide und darauf bezogene verfahren

Info

Publication number
ATE364690T1
ATE364690T1 AT02257796T AT02257796T ATE364690T1 AT E364690 T1 ATE364690 T1 AT E364690T1 AT 02257796 T AT02257796 T AT 02257796T AT 02257796 T AT02257796 T AT 02257796T AT E364690 T1 ATE364690 T1 AT E364690T1
Authority
AT
Austria
Prior art keywords
related methods
polypeptides
nucleic acid
posh nucleic
posh
Prior art date
Application number
AT02257796T
Other languages
English (en)
Inventor
Iris Alroy
Shmuel Tuvia
Tsvika Greener
Danny Ben-Avraham
Original Assignee
Proteologics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proteologics Inc filed Critical Proteologics Inc
Application granted granted Critical
Publication of ATE364690T1 publication Critical patent/ATE364690T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y603/00—Ligases forming carbon-nitrogen bonds (6.3)
    • C12Y603/02—Acid—amino-acid ligases (peptide synthases)(6.3.2)
    • C12Y603/02019—Ubiquitin-protein ligase (6.3.2.19), i.e. ubiquitin-conjugating enzyme

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT02257796T 2001-11-09 2002-11-11 Posh nukleinsäure, polypeptide und darauf bezogene verfahren ATE364690T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34584601P 2001-11-09 2001-11-09
US36453002P 2002-03-15 2002-03-15

Publications (1)

Publication Number Publication Date
ATE364690T1 true ATE364690T1 (de) 2007-07-15

Family

ID=26994569

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02257796T ATE364690T1 (de) 2001-11-09 2002-11-11 Posh nukleinsäure, polypeptide und darauf bezogene verfahren

Country Status (10)

Country Link
US (4) US7250250B2 (de)
EP (1) EP1310552B1 (de)
JP (1) JP2005519636A (de)
AT (1) ATE364690T1 (de)
AU (1) AU2002365160C1 (de)
CA (1) CA2465973C (de)
DE (1) DE60220621T2 (de)
IL (2) IL161764A0 (de)
NZ (1) NZ532908A (de)
WO (1) WO2003095971A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE458485T1 (de) 2003-07-11 2010-03-15 Proteologics Inc Ubiquitin-ligase-hemmer und verwandte verfahren
US20060188890A1 (en) * 2003-10-31 2006-08-24 Proteologics, Inc. Ubiquitin-based protein interaction assays and related compositions
CA2584131A1 (en) * 2004-10-15 2006-04-27 Signal Pharmaceuticals, Llc P27 ubiquitination assay and methods of use
US20090263821A1 (en) * 2004-12-01 2009-10-22 Proteologics, Inc. Ubiquitin Ligase Assays And Related Reagents
JP2008092911A (ja) * 2006-10-16 2008-04-24 Univ Of Tokyo タンパク質結合検出方法
KR101152615B1 (ko) 2007-08-30 2012-06-07 미쯔이 죠센 가부시키가이샤 형광공명에너지이동 검출 방법 및 장치
EP3067359A1 (de) 2008-09-23 2016-09-14 Scott G. Petersen Selbstfreisetzende biolabile phosphatgeschützte pro-oligos für therapeutika auf oligonukleotidbasis und vermittlung von rna-interferenz
US9901617B2 (en) * 2013-08-14 2018-02-27 The Curators Of The University Of Missouri Cell permeable inhibitors of the scaffold protein plenty of SH3 domains (POSH) or Sh3Rfl
WO2018085208A1 (en) 2016-11-02 2018-05-11 The Research Foundation For The State University Of New York Methods of inhibiting viruses using compositions targeting tsg101-ubiquitin interaction
CN106754883B (zh) * 2016-12-30 2019-10-29 中山大学 一种一步、无缝、非同源、多片段的基因拼接改造方法及其试剂盒
CN112764372A (zh) * 2020-12-25 2021-05-07 天津大学 基于vpx架构的多通道信号采集系统

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU770667B2 (en) * 1998-08-07 2004-02-26 Onyx Pharmaceuticals, Inc. CHP polypeptide, a ligand of PAK65
JP2003527824A (ja) * 1998-10-13 2003-09-24 オニックス ファーマシューティカルズ，インコーポレイティド ポリペプチドおよび核酸をシグナリングする新規細胞
WO2000027865A1 (en) 1998-11-06 2000-05-18 The Brigham And Women's Hospital, Inc. CHARACTERIZATION OF NOVEL GENE cbl-SL
WO2001064835A2 (en) 2000-02-28 2001-09-07 Hyseq, Inc. Novel nucleic acids and polypeptides
WO2001088088A2 (en) 2000-05-18 2001-11-22 Hyseq, Inc. Novel nucleic acids and polypeptides
EP1074617A3 (de) 1999-07-29 2004-04-21 Research Association for Biotechnology Primers für Synthese von ganzen-Länge cDNS und deren Anwendung
WO2001018542A2 (en) 1999-09-03 2001-03-15 Millennium Pharmaceuticals, Inc. Identification, assessment, prevention, and therapy of ovarian cancer
WO2001055321A2 (en) 2000-01-31 2001-08-02 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
CA2399776A1 (en) 2000-02-03 2001-08-09 Hyseq, Inc. Novel nucleic acids and polypeptides
AU2001241541A1 (en) 2000-02-17 2001-08-27 Millennium Predictive Medicine, Inc. Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of human prostate cancer
WO2001070979A2 (en) 2000-03-21 2001-09-27 Millennium Pharmaceuticals, Inc. Genes, compositions, kits, and method for identification, assessment, prevention and therapy of ovarian cancer
AU2001245945A1 (en) 2000-03-23 2001-10-03 Pe Corporation (Ny) Detection kits, such as nucleic acid arrays, for detecting the expression of 10,000 or more drosophila genes and uses thereof
US20020045170A1 (en) 2000-04-06 2002-04-18 Wong Gordon G. Polynucleotides encoding novel secreted proteins
JP2004509629A (ja) 2000-09-19 2004-04-02 ホワイトヘッド　インスチチュート　フォアー　バイオメディカル　リサーチ 腫瘍に対する遺伝子マーカー
EP1629082A4 (de) 2000-10-20 2009-07-22 Univ Massachusetts Mit glucosetransport in zusammenhang stehende gene und deren verwendungen
EP1334113A4 (de) 2000-10-20 2007-08-08 Expression Diagnostics Inc Erstellen von leukozytenexpressionsprofilen
WO2003008647A2 (en) 2000-11-28 2003-01-30 University Of Cincinnati Blood assessment of injury
WO2002077235A2 (en) 2000-12-21 2002-10-03 Incyte Genomics, Inc. Intracellular signaling molecules
WO2002053719A2 (en) * 2001-01-04 2002-07-11 Incyte Genomics, Inc. Cytoskeleton-associated proteins
EP1425302A2 (de) 2001-01-24 2004-06-09 Protein Design Labs Methoden zur diagnose von brustkrebs sowie methoden zur identifizierung von substanzen, die brustkrebs beeinflussen
US6743619B1 (en) 2001-01-30 2004-06-01 Nuvelo Nucleic acids and polypeptides
BR0207657A (pt) 2001-02-28 2004-10-26 Chondrogene Inc Uma ou mais sequências de polinucleotìdeos isoladas, vetor, célula hospedeira, composição, disposição, métodos para diagnosticar as osteoartrites branda, moderada, acentuada e grave em um paciente, para identificar um agente que aumenta ou diminui a expressão de uma sequência de polinucleotìdeos, para preparar uma coleção de cdna de condrócito, e para fabricar uma disposição, e conjunto
US20040236091A1 (en) 2001-03-28 2004-11-25 Chicz Roman M. Translational profiling
EP1383894A2 (de) * 2001-03-28 2004-01-28 Incyte Genomics, Inc. Moleküle zum nachweis und zur behandlung von krankheiten
WO2002085285A2 (en) 2001-04-18 2002-10-31 Wyeth Methods and reagents for regulating bone and cartilage formation
US7415358B2 (en) 2001-05-22 2008-08-19 Ocimum Biosolutions, Inc. Molecular toxicology modeling
WO2003022987A2 (en) 2001-07-26 2003-03-20 Eos Biotechnology, Inc. Methods of diagnosis of hepatitis c infection, compositions and methods of screening for modulators of hepatitis c infection
EP1560918A2 (de) 2001-07-31 2005-08-10 Proteologics, Inc. Zusammensetzungen und verfahren zur modulation der virusreifung
WO2003025138A2 (en) 2001-09-17 2003-03-27 Protein Design Labs, Inc. Methods of diagnosis of cancer compositions and methods of screening for modulators of cancer
MXPA04003382A (es) 2001-10-31 2004-11-22 Pfizer Prod Inc Agentes terapeuticos y diagnostico para transtornos de la eritropoyesis.
WO2003039490A2 (en) 2001-11-09 2003-05-15 Office Of Technology Licensing Stanford University Compositions and methods for diagnosing and treating mental disorders
US20040096828A1 (en) * 2002-01-04 2004-05-20 Lu Dyung Aina M Cytoskeleton-associated proteins

Also Published As

Publication number Publication date
AU2002365160A1 (en) 2003-11-11
IL161764A0 (en) 2005-11-20
EP1310552B1 (de) 2007-06-13
US20040025196A1 (en) 2004-02-05
WO2003095971A3 (en) 2005-04-28
HK1055996A1 (en) 2004-01-30
EP1310552A2 (de) 2003-05-14
US20060019240A1 (en) 2006-01-26
DE60220621D1 (de) 2007-07-26
JP2005519636A (ja) 2005-07-07
AU2002365160B2 (en) 2008-10-30
US7250250B2 (en) 2007-07-31
CA2465973C (en) 2013-04-16
EP1310552A3 (de) 2003-10-08
US20080187538A1 (en) 2008-08-07
DE60220621T2 (de) 2008-03-06
US7268227B2 (en) 2007-09-11
IL161764A (en) 2010-12-30
US20060035213A1 (en) 2006-02-16
WO2003095971A2 (en) 2003-11-20
CA2465973A1 (en) 2003-11-20
NZ532908A (en) 2008-04-30
AU2002365160C1 (en) 2009-08-13
US7429643B2 (en) 2008-09-30

Similar Documents

Publication Publication Date Title
ATE405647T1 (de) Rekombinantes gelatin in impstoffen
DE602004031681D1 (de) Multifunktionelle Cytokine
DE60114525D1 (de) Array-basierende Methoden zur Synthese von Nukleinsäuregemischen
DE69839557D1 (de) Klonierte genome von infektiösen hepatitis c viren und deren verwendungen
DE60032367D1 (de) Aktivierbare rekombinante neurotoxine
DE69739996D1 (de) Methoden und Zusammensetzungen zur Herstellung von Polypeptiden
DK2230299T3 (da) Hidtil ukendt cytokin ZCYTOR17-ligand
DE69534568D1 (de) Säugetier-telomerase
NZ521396A (en) Fusion proteins comprising two or more Neisseria polypeptides
ATE392430T1 (de) Verfahren zur herstellung von dipeptiden
DE60220621D1 (de) Posh Nukleinsäure, Polypeptide und darauf bezogene Verfahren
ATE368688T1 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
DE60010285D1 (de) Verfahren zur Herstellung von Amino-Oxide
AU2001241406A1 (en) Nucleic acids, proteins, and antibodies
DK1321477T3 (da) Fremgangsmåde til frembringelsen af genetisk modificerede vertebrate precursor-lymfocytter og anvendelse deraf til fremstillingen af heterologe bindende proteiner
IL184227A0 (en) Biologically active peptides
ATE506370T1 (de) Reagenzien und verfahren zur bildung von disulfid-bindungen und glykosylierung von proteinen
EP1558729A4 (de) Schnell abgebaute reporter-fusionsproteine
DE60239842D1 (de) Verfahren zur Herstellung von 10,11-dihydro-10-oxo-5h-dibenzoÄb,fÜazepin-5-carboxamid
DE60231149D1 (de) Zusammensetzungen mit hochgenauer dna-polymerase und verwendungen dafür
DE60030726D1 (de) Methode zur Herstellung von Mikropartikeln enthaltend biologisches Material
DE60032308D1 (de) Verfahren zur Herstellung von Trichloressigsäure
ATE320266T1 (de) Induktion von antigen-spezifischen t-zellen durch interferon
WO2003060067A3 (en) P85-alpha nucleic acids, polypeptides and related methods
IL160651A (en) Nucleic acid and corresponding protein entitled 205pib5 and pharmaceutical compositions containing the same and uses thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties